Abstract:Abstract Background Lung cancer remains the leading cause of mortality from malignant tumors, non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, and individualized diagnosis and treatment is an effective trend. The individual characteristics of different traditional Chinese medicine (TCM) syndromes of NSCLC patients may be revealed by highly specific molecular profiles. Methods In this study, 10 NSCLC patients with Qi deficiency and Yin deficiency (QDYD) syndrome and 10 patients with Qi deficiency of lung-spleen (QDLS) syndrome in TNM stage III-IV as well as 10 healthy volunteers were enrolled. Aiming at the varied syndromes of NSCLC patients with “Yin deficiency” as the main difference, a proteomics research based on data-independent acquisition (DIA) was developed. Of the dysregulated proteins in NSCLC patients, lipid metabolism was significantly enriched. Thereafter, nontargeted lipidomics research based on UPLC-Q-TOF/MS was performed in 16 patients, with 8 individuals randomly selected from each syndrome group. Furthermore, the considerably different characteristics between the syndromes and pathological mechanisms of NSCLC were screened by statistical and biological integrations of proteomics and lipidomics and the differential metabolic pathways of the two similar syndromes were further explored. Besides, lipids biomarkers were verified by a clinically used anticancer Chinese medicine, and the level of key differential proteins in the two syndromes was also validated using ELISA. Results The results showed that glycerophospholipid metabolism, sphingolipid metabolism, glycolipid metabolism, and primary bile acid biosynthesis were altered in NSCLC patients and that glycerophospholipid metabolism was significantly changed between the two syndromes in lipidomics analysis. Among the proteins and lipids, ALDOC and lysophosphatidylcholine (LPCs) were revealed to have a strong relationship by statistical and biological integration analysis, and could effectively distinguish QDLS and QDYD syndromes. Notably, the patients with different syndromes had the most typical metabolic patterns in glycerophospholipid metabolism and glycolysis, reflecting the differences in the syndromes dominated by “Yin deficiency”. Conclusions ALDOC and LPCs could be employed for the differentiation of NSCLC patients with QDLS and QDYD syndromes, and “Yin deficiency” might be associated with glycerophospholipid metabolism and glycolysis pathway. The results provided a theoretical basis for “Syndrome differentiation” in TCM diagnosis. Moreover, the developed integrated strategy could also provide a reference for individualized diagnosis and treatment of other diseases.

PDMS-TiO2 Composite Films Combined with LC-MS/MS for Determination of Phospholipids of Urine in Non-Small Cell Lung Cancer Patients with Traditional Chinese Medicine Syndromes.

Urine Metabolic Profiling for Rapid Lung Cancer Screening: A Strategy Combining Rh-Doped SrTiO3-Assisted Laser Desorption/Ionization Mass Spectrometry and Machine Learning

Efficient Serum Lipids Profiling by TiO2-dopamin-assisted MALDI-TOF MS for Breast Cancer Detection

Biofluids Metabolic Profiling Based on PS@Fe 3 O 4 –NH 2 Magnetic Beads-Assisted LDI-MS for Liver Cancer Screening

Lysophosphatidylcholine Biomarkers of Lung Cancer Detected by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Mass Spectrometry

High-Throughput Salivary Metabolite Profiling on an Ultralow Noise Tip-Enhanced Laser Desorption Ionization Mass Spectrometry Platform for Noninvasive Diagnosis of Early Lung Cancer.

A Method of Detecting Two Tumor Markers (P-Hydroxybenzoic Acid and P-Cresol) in Human Urine Using a Porous Magnetic -Cyclodextrine Polymer As Solid Phase Extractant, an Alternative for Early Gastric Cancer Diagnosis.

Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes

TiO2@COF-based Solid-Phase Microextraction Combined with UHPLC-MS/MS for the Rapid Determination of Potential Biomarkers of Phosphatidylcholines and Lysophosphatidylcholines in Head and Neck Cancers.

Development of a Headspace-Solid Phase Microextraction Gas Chromatography-High Resolution Mass Spectrometry Method for Analyzing Volatile Organic Compounds in Urine: Application in Breast Cancer Biomarker Discovery

Determination of Thiol Metabolites in Human Urine by Stable Isotope Labeling in Combination with Pseudo-Targeted Mass Spectrometry Analysis

Probing Gender-Specific Lipid Metabolites and Diagnostic Biomarkers for Lung Cancer Using Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Simultaneous Determination of Phytoestrogens and Key Metabolites in Breast Cancer Patients’ Urine by Liquid Chromatography–tandem Mass Spectrometry

Simultaneous determination of three biomarkers of non-small cells lung cancer in urine by pipette-tip solid-phase extraction coupled with liquid chromatography tandem mass spectrometry

Discriminating Patients With Early-Stage Breast Cancer From Benign Lesions By Detection Of Oxidative Dna Damage Biomarker In Urine

Application of Laser Capture Microdissection and Surface-enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Biomarkers for Early Diagnosis of Lung Adenocarcinoma

Ultrasensitive and High Reproducible Detection of Urinary Metabolites Using the Tip–Contact Extraction Method Coupled with Negative LDI-MS

Screening and Identification of Potential Novel Lipid Biomarkers for Non‐small Cell Lung Cancer Using Ultra‐high Performance Liquid Chromatography Tandem Mass Spectrometry

Correction To: A New Methodology to Reveal Potential Nucleic Acid Modifications Associated with the Risk of Endometrial Cancer Through Dispersive Solid‑phase Extraction Coupled with UHPLC‑QE‑Orbitrap‑MS/MS and HPLC–UV

Altered Phosphatidylcholines Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer.

Simultaneous Quantification of Serum Multi-Phospholipids As Potential Biomarkers for Differentiating Different Pathophysiological States of Lung, Stomach, Intestine, and Pancreas.